Low-dose antithymocyte globulin for treatment of steroid-pulse - Resistant acute graft-versus-host disease [4]

International Journal of Hematology

Volumn 77, Issue 1, 2003, Pages 99-102

  Ohashi, Kazuteru ^a   Tanaka, Yuji ^a   Mori, Shin Ichiro ^a   Okuyama, Yoshiki ^a   Hiruma, Kiyoshi ^a   Akiyama, Hideki ^a   Sakamaki, Hisashi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; LETTER; MALE; OPPORTUNISTIC INFECTION; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; ACUTE DISEASE; DRUG RESISTANCE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTILYMPHOCYTE SERUM; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; STEROIDS; TREATMENT OUTCOME;

EID: 0037974815     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982612     Document Type: Letter

References (8)

1. Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotorexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062-2068.
2. Deeg HJ, Loughran TP Jr, Storb R, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation. 1985; 40:162-166.
3. Basara N, Kiehl MG, Blau W, et al. Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience. Transplant Proc. 2001; 33:2121-2123.
4. Racadot E, Milpied N, Bordigoni P, et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients. Bone Marrow Transplant. 1995;15:669-677.
5. Dugan MJ, DeFor TE, Steinbuch M, et al. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival. Ann Hematol. 1997;75:41-46.
6. McCaul KG, Nevill TJ, Barnett MJ, et al. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. J Hematother Stem Cell Res. 2000;9:367-374.
7. Khoury H, Kashyap A, Adkins DR, et al. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant. 2001;27:1059-1064.
8. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97: 855-864.